Revvity, Inc. (NYSE:RVTY) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Revvity, Inc. (NYSE:RVTY) have earned a consensus rating of “Moderate Buy” from the thirteen research firms that are covering the stock, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $136.25.

Several research firms have issued reports on RVTY. Barclays upped their price objective on Revvity from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Raymond James reaffirmed an “outperform” rating and set a $145.00 price objective (up previously from $140.00) on shares of Revvity in a report on Monday, February 3rd. Bank of America raised Revvity from a “neutral” rating to a “buy” rating and set a $138.00 price objective on the stock in a report on Friday, December 13th. KeyCorp upped their price objective on Revvity from $132.00 to $145.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Finally, Sanford C. Bernstein downgraded Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price target on the stock. in a research note on Friday, January 10th.

Revvity Stock Down 1.1 %

Shares of RVTY opened at $111.73 on Thursday. The business’s 50 day simple moving average is $117.08 and its 200-day simple moving average is $118.10. Revvity has a one year low of $97.32 and a one year high of $129.50. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The company has a market capitalization of $13.42 billion, a P/E ratio of 50.55, a PEG ratio of 3.82 and a beta of 1.06.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same quarter in the prior year, the business posted $1.25 EPS. As a group, sell-side analysts predict that Revvity will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.25%. The ex-dividend date is Thursday, April 17th. Revvity’s dividend payout ratio is currently 12.67%.

Insider Activity at Revvity

In other Revvity news, insider Tajinder S. Vohra sold 5,492 shares of the stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total transaction of $641,520.52. Following the completion of the transaction, the insider now owns 19,652 shares in the company, valued at approximately $2,295,550.12. This represents a 21.84 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Joel S. Goldberg sold 15,170 shares of the stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the transaction, the insider now owns 33,400 shares of the company’s stock, valued at approximately $4,232,782. This trade represents a 31.23 % decrease in their position. The disclosure for this sale can be found here. 0.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Revvity

A number of large investors have recently added to or reduced their stakes in the company. Dogwood Wealth Management LLC increased its holdings in Revvity by 16.8% during the 4th quarter. Dogwood Wealth Management LLC now owns 4,987 shares of the company’s stock worth $557,000 after purchasing an additional 717 shares in the last quarter. Siemens Fonds Invest GmbH grew its holdings in shares of Revvity by 264.8% in the 4th quarter. Siemens Fonds Invest GmbH now owns 13,357 shares of the company’s stock valued at $1,491,000 after acquiring an additional 9,696 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Revvity in the 4th quarter valued at about $16,293,000. Vermillion Wealth Management Inc. bought a new position in shares of Revvity in the 4th quarter valued at about $41,000. Finally, Mackenzie Financial Corp grew its holdings in shares of Revvity by 22.3% in the 4th quarter. Mackenzie Financial Corp now owns 14,381 shares of the company’s stock valued at $1,605,000 after acquiring an additional 2,619 shares in the last quarter. Institutional investors own 86.65% of the company’s stock.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.